ERBB2 and breast carcinoma: Human epidermal growth factor receptor 2 (HER2) positive breast cancer accounts for approximately 20%–25% of all breast cancer and is associated with aggressive behavior and poor prognosis (Owens et al., 2004; Cronin et al., 2010).